Patient Video - How has your KRAS mutation affected the treatment options available to you?
Terri discusses her treatment journey for her KRAS G12D-positive lung cancer. Currently there are no targeted treatments approved for the KRAS G12D lung cancer mutation, but knowing her mutation is important because it provides information on what treatment options are available to her for immunotherapy, surgery, or radiation. She is hopeful about the new treatments that are being researched in clinical trials.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
